π
|
Cost-effectiveness of CT screening in the National Lung Screening Trial.
11 auth.
W. Black,
I. Gareen,
S. Soneji,
Jorean D. Sicks,
E. Keeler,
D. Aberle,
...
A. Naeim,
T. Church,
G. Silvestri,
J. Gorelick,
C. Gatsonis
|
8 |
2014 |
8 π
|
π
|
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
19 auth.
M. Machtay,
F. Duan,
B. Siegel,
B.S. Snyder,
J. Gorelick,
Janet S. Reddin,
R. Munden,
Douglas Johnson,
L. H. Wilf,
A. Denittis,
...
N. Sherwin,
K. Cho,
Seok-ki Kim,
G. Videtic,
D. Neumann,
R. Komaki,
H. Macapinlac,
J. Bradley,
A. Alavi
|
7 |
2013 |
7 π
|
π
|
3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve forΒ Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial.
14 auth.
D. Kenny,
J. Rhodes,
Gregory A. Fleming,
S. Kar,
E. Zahn,
J. Vincent,
G. Shirali,
J. Gorelick,
M. Fogel,
J. Fahey,
...
Dennis W. Kim,
V. Babaliaros,
Aimee K. Armstrong,
Z. Hijazi
|
6 |
2018 |
6 π
|
π
|
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.
11 auth.
N. Ohri,
F. Duan,
M. Machtay,
J. Gorelick,
B.S. Snyder,
A. Alavi,
...
B. Siegel,
Douglas Johnson,
J. Bradley,
A. Denittis,
M. Werner-Wasik
|
6 |
2015 |
6 π
|
π¬
|
Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
K. Atkinson,
D. Fine,
Lori A. Thombs,
J. Gorelick,
H. E. Durham
|
6 |
2009 |
6 π¬
|
π
|
Alterra Adaptive Prestent and SAPIEN 3 THV for Congenital Pulmonic Valve Dysfunction: An Early Feasibility Study.
12 auth.
S. Shahanavaz,
D. Balzer,
V. Babaliaros,
Dennis W. Kim,
V. Dimas,
S. R. Veeram Reddy,
...
J. Leipsic,
P. Blanke,
G. Shirali,
A. Parthiban,
J. Gorelick,
E. Zahn
|
5 |
2020 |
5 π
|
π
|
The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health.
7 auth.
M. Clark,
J. Gorelick,
Jorean D. Sicks,
E. Park,
Amanda L. Graham,
D. Abrams,
...
I. Gareen
|
5 |
2015 |
5 π
|
π
|
TCT-8 Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System
8 auth.
R. Makkar,
W. OβNeill,
B. Whisenant,
M. Guerrero,
T. Feldman,
C. Rihal,
...
J. Gorelick,
J. Webb
|
4 |
2019 |
4 π
|
π
|
Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233
16 auth.
M. Atri,
Zheng Zhang,
H. Marques,
J. Gorelick,
M. Harisinghani,
A. Sohaib,
D. Koh,
S. Raman,
M. Gee,
Haesun Choi,
...
L. Landrum,
R. Mannel,
L. Chuang,
J. Yu,
C. McCourt,
M. Gold
|
3 |
2014 |
3 π
|